Moreover, the studies into estrogen and 3D genome structure changes have been focused mainly on breast cancer, while its effect in endometrial cancer, where we have previously shown that ER regulates different genes than in breast cancer (Rodriguez et al. 2020), is poorly understood. The gene discussed is ESR1; the disease is endometrial cancer.